REHOVOT, Israel, April 17, 2025 /PRNewswire/ — Sequentify is offering research grants to accelerate high-impact genomic studies through its uniquely fast, easy-to-use, and scalable targeted library preparation technology. Designed to enable the widespread adoption of high-throughput genomic testing, Sequentify’s protocol is ideal for large-scale programs conducting targeted sequencing at the population or cohort level.
We invite proposals from research groups conducting genomic DNA studies using human-derived samples, regardless of research field. Eligible areas include, but are not limited to: oncology, rare disease, reproductive health, infectious disease, population screening, and public health.
To qualify, proposed studies must:
Selected applicants will receive:
Submission Guidelines: In up to 250 words, describe how this grant would enhance your research and contribute to your scientific field.
Application period: April 5 – June 20, 2025
Submit applications to: hello@sequentify.com
If you have questions about the grant or your project’s eligibility, feel free to reach out to us at the same address—we’d be happy to help.
About Sequentify:
Founded in 2021 as a Weizmann Institute spinoff, Sequentify enables decentralized, population-wide genomic sequencing by providing laboratories with the easiest and quickest solutions available. Their technology facilitates the scaling-up of genomic testing by directly addressing the current pain points in the industry, through sample-prep and software solutions. The company offers panels for oncology and screening applications, and infectious diseases, with a focus on the clinical market. Sequentify is based in Rehovot, Israel. For more information about the company, visit https://www.sequentify.com/.
Media Contact:
Avigayil Simpson
avigayil@sequentify.com
Logo: https://healthtechnologynet.com/wp-content/uploads/2025/04/SEQUENTIFY_Logo.jpg
SOURCE Sequentify
GALWAY, Ireland, Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in…
This app will connect people with strangers to meditate together in the real world—an invitation…
Despite challenging framework conditions such as high energy prices, the international introduction of tariffs, and…
ATLANTA, Dec. 19, 2025 /PRNewswire/ -- Switchboard, MD is proud to announce a new enterprise partnership with…
MCLEAN, Va., Dec. 19, 2025 /PRNewswire/ -- Sierra7, a leader in government healthcare and technology solutions,…
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Medome is the first AI technology for Personal Health…